NCT01826461 An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT01808157 A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT01806662 Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT01805635 PF and FeNO and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic Diseases Status UNKNOWN Phase N/A
NCT01789619 Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients Status COMPLETED Phase N/A
NCT01785602 Efficacy and Safety Study of QAW039 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis. Status COMPLETED Phase PHASE2
NCT01782703 Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01781663 Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD) Status UNKNOWN Phase PHASE4
NCT01756898 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT01732510 A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003) Status TERMINATED Phase PHASE1
NCT01714245 A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients Status COMPLETED Phase N/A
NCT01702181 A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT01695707 Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients Status WITHDRAWN Phase NA
NCT01689805 Clinical Importance of Filaggrin Gene Mutation for Treatment Outcome in Atopic Dermatitis Status UNKNOWN Phase N/A
NCT01686048 The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel Status COMPLETED Phase N/A
NCT01678092 Single Center Study Using Omalizumab in Subjects With Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT01675232 A Study Comparing the Efficacy of Two Topical Steroid Application Regimens in Pediatric Patients With Atopic Dermatitis Status COMPLETED Phase NA